Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OriGene Launches Genome-wide Gene-knockout Kits Using CRISPR Platform

Published: Thursday, May 08, 2014
Last Updated: Thursday, May 08, 2014
Bookmark and Share
A complete solution to knock out a human gene at the chromosomal level.

OriGene Technologies has launched a new product line of gene-knockout kits using CRISPR technologies. The new products provide a complete solution for researchers to knock out a human gene at the chromosomal level. This genome wide offering provides an unprecedented convenience for genome editing using the CRISPR technology.

OriGene has always been focused on providing reagents of highest quality. Its comprehensive offering of expression cDNA clones, shRNA/siRNA, recombinant proteins and antibodies are widely utilized in the biomedical research community world-wide and are cited in thousands of publications.

“CRISPR is a revolutionary tool for biomedical scientists. Our dream of a pair of simple accurate molecular scissor is now a reality. As the world’s largest supplier of molecular tools, OriGene is excited to be in the middle of this technology boom. Launching genome-wide knock-out kits is only the very first step for OriGene to help harness the power of the CRISPR technology.” said Dr. Wei-Wu He, CEO and Chairman of OriGene.

“An established leader in the molecular biology market, especially utilizing its US-based gene-synthesis capacity, OriGene is in a perfect position to provide genome wide CRISPR tools to the research community.” Remarked Dr. Youmin Shu, SVP of Molecular Biology.

Dr. Shu continued, “We provide a kit against every human gene locus, containing 2 gRNAs and a compatible donor vector with a functional cassette. In additional to gene knockout, this kit can also be used for promoter strength study for each gene locus. The pre-designed nature of the kit greatly reduces the researcher’s time and effort using this great platform.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OriGene Awarded NCI Contract
The contract will see OriGene to develop high affinity anti-peptide antibodies for SISCAPA assays.
Monday, February 03, 2014
OriGene Technologies Announces the Acquisition of ZsBio
Acquisition establishes OriGene's leading position in the Chinese pathology testing market.
Tuesday, March 13, 2012
OriGene Releases 1500 TrueMAB™ Monoclonal Antibodies
Extensively validated monoclonal antibodies made against native protein antigens for superior IHC, IF, ELISA and flow applications.
Monday, January 24, 2011
OriGene Technologies Acquires Blue Heron Biotechnology
OriGene’s collection of human cDNA clones together with Blue Heron’s gene synthesis capacity provides a whole product solution for the life sciences community.
Tuesday, August 17, 2010
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
How a Kernel Got Naked and Corn Became King
Ten thousand years ago, a golden grain got naked, brought people together and grew to become one of the top agricultural commodities on the planet.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!